115 results about "Bifidobacterium infantis" patented technology

This invention relates to a composition suitable for use in the prevention of opportunistic infections in immune-compromised individuals comprising a probiotic Bifidobacterium lactis, Bifidobacterium infantis, Bifidobacterium breve or Bifidobacterium longum and a fucosylated oligosaccharide selected from the group comprising 2′-fucosyllactose, 3′fucosyllactose, difucosyllactose, lacto-N-fucopentaose, lacto-N-fucohexaose, fucosyllacto-N-hexaose and fucosyllacto-N-neohexaose. The invention further extends to the use of such a composition in the prevention of opportunistic infections in immune-compromised individuals.

The invention relates to a drink, in particular to a probiotic type fruit and vegetable enzyme solid drink. The probiotic type fruit and vegetable enzyme solid drink is prepared from raw materials in parts by mass as follows: 10-50 parts of prebiotics, 5-40 parts of water-soluble dietary fiber, 0-20 parts of sugar alcohol, 0.1-15 parts of fruit powder, 0.1-10 parts of fruit and vegetable enzyme powder, 0.01-15 parts of freeze-dried bifidobacterium infantis powder, 0.01-20 parts of freeze-dried bifidobacterium breve powder, 0.01-30 parts of freeze-dried Lactobacillus plantarum powder, 0.01-25 parts of freeze-dried bifidobacterium longum powder and 0.01-20 parts of freeze-dried Lactobacillus casei powder. The probiotic type fruit and vegetable enzyme solid drink adopts the natural raw materials and the scientific formula and is balanced in nutrition and beneficial to intestinal health and body immunity.

The invention discloses the syndrome of diarrhea with loose and fetid stools caused by harmful bacteria in intestine, especially relates to a kind of probiotics and prebiotics used for treating said syndrome and the compound product. Said probiotics comprises bacillus coagulans, butanoic acid clostridial vaccine, infant bifidobacteria, young bifidobacteria, long bifidobacteria, Bifidobacterium bifidum and bacillus subtilis, and etc. The prebiotics can be soybean oligosaccharide and other oligosaccharides. The probiotics and prebiotics and their compound can be taken orally, and they can remove indole, scatal, sulfur, amino and amine from intestinal canal.

The invention relates to baby bifidobacterium, a medicine combination, application of the baby bifidobacterium and the medicine combination and manufacturing method of the baby bifidobacterium and the medicine combination and provides a baby bifidobacterium bacterial strain IFA09 and a preservation number of the baby bifidobacterium bacterial strain is CCTCC NO:M2011310. The baby bifidobacterium has high activity and is capable of effectively treating gastrointestinal neurosis diseases. In addition, a vaccination liquid culture medium enables activity of a vaccination to be enhanced, a fermentation medium is stable in composition, quality and production conditions are easy to control, industrialized production at 500L can be achieved, high intensity culture of 1010cfu/mL can be achieved and production requirements can be completely satisfied. The invention provides a freezing and drying protecting agent and freezing and drying technology which can improve a viable bacteria rate and prolong storage time of the freezing and drying protecting agent and thus stability of the agent is improved.

The invention belongs to the technical field of food processing, and relates to the technical field of probiotics nutrients, in particular to five-probiotic nutritive powder and a preparation method thereof. The five-probiotic nutritive powder provided by the invention comprises the following raw material components in parts by weight: 2-9 parts of lactobacillus reuteri, 3-9 parts of bifidobacterium lactis, 3-6 parts of bifidobacterium infantis, 2-8 parts of bifidobacterium animalis, 4-11 parts of lactobacillus rhamnosus, 18-38 parts of stachyose, 26-39 parts of fructo-oligosaccharide and 56-86 parts of maltodextrin. The formula of the five-probiotics nutritive powder disclosed by the invention is suitable for babies and middle-aged and old people to use, five-probiotics powder suitable for the babies and the middle-aged and old people to eat can be obtained, the internal environment of the intestinal tracts can be improved, probiotics in the intestinal tracts can be in a dominant position, the propagation and the growth of harmful funguses can be restrained, toxins are degraded, the immunity of the babies and the middle-aged and old people can be enhanced, and the health of human bodies can be promoted.

The invention discloses a plant composite ferment capable of adjusting intestinal floras and a preparation method thereof. The plant composite ferment is mainly prepared by uniformly mixing botanical raw materials consisting of black fungi, citrus fiber, oat bran and konjak powder according to a certain weight ratio, then adding probiotics for fermentation and carrying out blending with prebiotics and dietary fiber, wherein probiotics are one or more selected from a group consisting of Bifidobacterium adolescentis, Bifidobacterium lactis, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium longum, Bifidobacterium bifidum, Lactobacillus acidophilus, Lactococcus lactis subsp. cremoris, Lactococcus lactis subsp. diacetyl, Leuconostoc mesenteroides subsp. mesenteroides, conventional bacterial strains for food production and processing, etc.; and the prebiotics and dietary fiber are one or more selected from a group consisting of inulin, L-arabinose and stachyose. The plant composite ferment provided by the invention can provide beneficial bacteria for the intestinal tracts of people, is applicable as a raw material for metabolism of intestinal floras and has good effect on adjustment of the functions of intestinal floras.

The invention relates to the technical field of food enzymes, and discloses a symbiotic microflora enzyme. The symbiotic microflora enzyme contains symbiotic microflora which has the effect of preventing, resisting and inhibiting helicobacter pylori. The symbiotic microflora contains main microflora and auxiliary microflora which aim at enhancing microflora effects and increasing the microflora number, wherein the main microflora comprises lactobacillus acidophilus, lactobacillus bulgaricus, lactobacillus plantarum, lactobacillus rhamnosus, Roy's lactobacillus, lactobacillus casei, lactobacillus gasseri, lactobacillus johnsonii, lactobacillus salivarius, lactobacillus brevis, lactic streptococci, bacillus subtilis, bifidobacterium bifidum, bifidobacterium adolescentis, bifidobacterium infantis, bifidobacterium breve and bifidobacterium longum. After the symbiotic microflora enzyme is drunk, the contained powerful and rich symbiotic microflora can naturally exist in the digestive system of the human body, obtains the living space advantage in the ecological environment, and achieves the effect of eliminating helicobacter pylori.

Compositions comprising bifidobacteria and galactooligosaccharides and fructooligosaccharides are provided that support the introduction of solid weaning foods in the diet of infants that receive infant milk formula or breast milk.

The invention discloses a composite culture medium for fermentation of bifidobacteria and the manufacturing method, which comprises the following parts: 50-150g spirulina powder, 40-80g stachyose, 30-100ml 5% pork liver infusion, 1000ml distilled water. The effect of the invention is that: the infant bifidobacteria, adolescent bifidobacteria and long bifidobacteria grow well in the culture medium; the maximum increment reaches 1010cfu/ml in the best fermentation condition; the submerged culture effect is the best of the classic bifidobacteria selective culture medium, TPY culture medium and improved TPY culture medium. The composite culture medium provides a simple formulation, a low cost, a simple manufacturing process, which can be used to the research, exploitation, production of bifidobacteria, provides the important meanings of utilizing and developing spirulina and stachyose resource.

The invention discloses a preparation method of a composite probiotic agent for preventing and treating diabetes and controlling body weight, in particular to a composite probiotic agent formed by compounding probiotics, prebiotics and metformin and used for preventing and treating diabetes and controlling body weight and a preparation method of the composite probiotic agent. Beneficial bacteria such as clostridium butyricum, saccharomyces boulardii, lactobacillus reuteri, bifidobacterium infantis, bacillus licheniformis and the like, the prebiotics such as arabinose and xylooligosaccharide, and metformin are combined to avoid symptoms such as nausea, emesis, diarrhea, abdominal pain, constipation, abdominal distention, dyspepsia, heartburn and the irritable bowel syndrome which are caused by the metformin, the curative effect is good, glucose metabolism is accelerated by directly absorbing and utilizing glucose, and effects of controlling body weight and treating the diabetes are improved. In the aspect of improving adverse effects of the metformin drug to a gastrointestinal tract, the effect of the composite probiotic agent is higher than that of the metformin which is applied purely.

The invention discloses a preparation method of Bifidobacterium infantis microcapsules. The microcapsules are prepared with edible gelatin and gum as microcapsule wall materials and Bifidobacterium infantis as a core material by a water phase separation method. The preparation method uses an enzyme as a cross-linking agent to prepare microcapsules, and the prepared microcapsules have strong gastric acid resistance. The preparation method disclosed by the invention has the advantages of simpleness in process, safety in administration, and on the like. The preparation method improves the utilization ratio of Bifidobacterium infantis, ensures the important roles of Bifidobacterium infantis in regulating microbial balance in infant intestinal tract, promoting infant health growth, and the like, and can effectively promote the application of Bifidobacterium infantis in infant formula milk.

The invention provides bifidobacterium infantis, which is applied to foods or medicines for preventing and treating food allergy. The bifidobacterium infantis is preserved in China General Microbiological Culture Collection Center with preservation number of CGMCC NO.0313-2. According to the invention, two mice of esophagus allergy are established on the basis of intensive study on a relation between allergic diseases and probiotics; and an unexpected technical effect is achieved when the bifidobacterium infantis is applied to the foods or medicines for preventing the food allergy; therefore, a novel solution is provided for preventing the food allergy.

The invention relates to a probiotic formulated milk powder and a preparation method thereof. The probiotic formulated milk powder comprises a milk powder raw material, a milk powder auxiliary material and a nutrient supplement. The probiotic formulated milk powder is characterized in that the nutrient supplement comprises at least one or more probiotics and one or more selected from a group consisting of taurine, vitamin A, vitamin D, vitamin E, vitamin C, folic acid, calcium carbonate, ferrous sulfate and zinc sulfate, and the percentages of the above components are mass percentages of the components in the milk powder. Compared with the prior art, the invention has the advantages that the above materials produce acid and fragrance after fermentation by Streptococcus thermophilus and Lactobacillus bulgaricus, so the produced probiotic formulated milk powder has unique taste and smell and is more popular among consumers; and Bifidobacterium animalis Bb-12, Bifidobacterium lactis, Lactobacillus acidophilus, Lactobacillus plantarum, Bifidobacterium amphibians, Lactobacillus rhamnosus, Lactobacillus casei and Bifidobacterium infantis blended into the milk powder in a dry mixing manner have functions as described in the specification.

The invention discloses a lactic acid bacterium composition for protecting the gastrointestinal mucosa. The lactic acid bacterium composition comprises the following components in parts by weight: 5-20 parts of bifidobacterium lactis, 0.5-2 parts of bifidobacterium infantis, 8-25 parts of lactobacillus rhamnosus, 3-20 parts of lactobacillus acidophilus, 3-20 parts of lactobacillus plantarum and 8-25 parts of lactobacillus salivarius. The invention further discloses a processing method for the lactic acid bacterium composition. The processing method comprises the following steps: (1), preparing sclerotia; (2), embedding non-reducing sugar; (3), embedding skimmed milk; and (4), freeze-drying. The lactic acid bacterium composition provided by the invention has the advantages of adjusting gastrointestinal microorganisms to be balanced and protecting the gastrointestinal mucosa.

The invention relates to the related technical field of food processing, and more particularly provides bifidobacterium infantis freeze-dried powder, a preparation method and a composite protective agent used by the bifidobacterium infantis freeze-dried powder. The invention provides a bifidobacterium freeze-dried powder composite protective agent which comprises the following components in percentage by weight: 10-30% of skim milk powder, 0.1-5.0% of amino acid and salt thereof, 3-25% of disaccharide or/and polysaccharide, 1-5% of micromolecular polyhydric alcohol and the balance of phosphatebuffer solution, wherein a pH value of the composite protective agent is 6.5-8.5. Through the combined action of the specific composite protective agent and an auxiliary agent, the survival rate andthe viable count of the bifidobacterium infantis freeze-dried powder can be remarkably increased, and the problems that the bifidobacterium infantis powder is low in survival rate, small in viable count, short in preservation period and the like in the freeze-drying process are solved.

The invention relates to the field of yoghourt processing, in particular to functional yoghourt with long shelf life and a preparation method thereof. The preparation method of the functional yoghourt with long shelf life according to the invention comprises the following steps of: (1) uniformly mixing raw materials, degassing, homogenizing and sterilizing; (2) adding fermentation species, fermenting, filling, and performing post maturation to obtain a finished product; (3) and performing radiation sterilization on the finished product obtained in the step (2) with the radiation dose between 3 kGy and 6 kGy to obtain the functional yoghourt with long shelf life, wherein the fermentation species in the step (2) comprise bifidobacterium infantis. Radiation sterilization is performed with the radiation dose between 3 kGy and 6 kGy, so that the shelf life of the yoghourt can be prolonged; meanwhile, the bifidobacterium infantis is added into the yoghourt, so that the product is endowed with an antitumor function. The yoghourt prepared by using the method has good tissue state, mouthfeel and flavor, does not undergo great changes in the aspects of color, mouthfeel, flavor and tissue within the storage time of six months, and has high stability.

The invention discloses a gene engineering bacteria capable of producing bile salt hydrolase and a construction method and application thereof, and belongs to the technical field of gene engineering. According to the gene engineering bacteria capable of producing the bile salt hydrolase and the construction method and application thereof, by adopting a recombinant DNA technology, the bile salt hydrolase (bsh) of Bifidobacterium infantis KL412 is connected to a prokaryotic expression vector pET-22b(+) in a gene-cloning mode and converted into Escherichia coli BL21(DE3), and recombinant Escherichia coli BL21(DE3)-pET-22b(+)-bsh capable of producing the high-activity bile salt hydrolase is obtained through screening and identifying. 2% inoculation amount of seed liquid is inoculated to a fermentation medium, the recombinant bacteria is induced for 32 h to reach the highest enzyme activity on the condition that the temperature is 20 DEG C, OD<600> is 2.0, and IPTG is 1 mmol/L, and the enzyme activities of the recombinant bacteria for glycodeoxycholic acid sodium (GDCA) and taurodeoxycholic acid sodium (TDCA) are 135.2 U/mL and 121.3 U/mL respectively. Therefore, a good foundation is laid for large-scale production of the bile salt hydrolase and using the bile salt hydrolase as functional food to decrease serum cholesterol.

The invention belongs to the technical field of fish breeding and particularly relates to a feeding method for high nutrient carps. The feeding method comprises the following specific steps: feeding bait A at seven o'clock every morning; and feeding bait B at thirty past four every afternoon, wherein the bait A is prepared from the following raw materials: bean pulp, fresh fiery dragon peels, buckwheat, fresh flos sophorae, bifidobacterium infantis, mesona blumes polysaccharide, garlic, apples and corn oil; and the bait B is prepared from the following raw materials: tomato seed pulp, fresh flavedo, broomcorn, fresh folium mori, bifidobacterium adolescentis, algal polysaccharides, onions, lemons and corn oil. The feeding method can be used for balancing nutrients effectively, improving thedigestive absorption conversion efficiency of nutrients, improving the utilization ratio of the bait, reducing the intestines problems, improving the contents of nutritional substances such as proteins, zinc and vitamin A of the carps effectively, improving the nutritional value, promoting the human health, promoting quick growth of the carps effectively, shortening the breeding period effectively, lowering the breeding cost and improving the economical benefit of farmers.

The invention belongs to the technical field of probiotics, and more specifically discloses probiotics capable of improving symptoms of patients with autism spectrum disorders. The probiotics capableof improving symptoms of patients with autism spectrum disorders are composed of Lactobacillus bulgaricus, Bifidobacterium infantis, Bifidobacterium longum, Bifidobacterium bifidum, Lactobacillus acidophilus, and Lactobacillus casei at a mass ratio of 1-6:2-7:2-5:1-3:0.8-2.5:0.5-2. According to a preparation method, microbiome-gut-brain axis effect mechanism is adopted, a scientific ratio is adopted, so that that probiotics capable of improving symptoms of patients with autism spectrum disorders are prepared. The probiotics are capable of improving the core symptoms of patients with autism spectrum disorders, the autism spectrum disorder patient behavior improvement rate is 80%, the constipation improvement rate is 80%, the diarrhoea improvement rate is 40%, the emotion improvement rate is21%, the diet improvement rate is 16%, and the sleep quality improvement rate is 12%.

The present application relates to probiotic compositions, e.g., comprising at least one bacterial strain selected from: Streptococcus thermophiles, Bifidobacterium longum, Bifidobacterium breve, Bifidobacterium infantis, Lactobacillus acidophilus, Lactobacillus plantarum, Lactobacillus paracasei, KE99, and Lactobacillus bulgaricus, optionally wherein the at least one bacterial strain is either alive or sonicated.

The invention relates to a multifunctional composite probiotic preparation as well as a preparation method and the application thereof. The multifunctional composite probiotic preparation is prepared from lactobacillus plantarum MiuCul-01, lactobacillus acidophilus MiuLac-01, lactobacillus casei MiaoTech-01, lactobacillus rhamnosus MiaoTech-11, streptococcus thermophilus MiaoPro-01, bifidobacterium bifidum Miuyo-01, bifidobacterium lactis Miuyo-11, bifidobacterium infantis Miuyo-21 and bifidobacterium breve Miuyo-31, and the multifunctional composite probiotic preparation is prepared from lactobacillus plantarum MiuCul-01, lactobacillus acidophilus MiuLac-01, lactobacillus casei MiaoTech-01, lactobacillus rhamnosus MiaoTech-11, streptococcus thermophilus The composite probiotic preparation is prepared by a new process combining mixed bacteria inoculation, anaerobic liquid culture, solid-liquid separation, solid culture and the like, and the produced composite probiotic preparation is large in thallus quantity and high in activity, and contains metabolites generated by probiotics; the traditional Chinese medicine composition has better effects of resisting helicobacter pylori, reducing blood sugar, coordinating intestines and stomach, enhancing immunity, resisting allergy, reducing fat, losing weight and the like in human gastrointestinal tracts.